Vanta Bioscience Limited (VANTABIO.BO)
INR 24.2
(0.0%)
INR 24.2
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 853.96 Million INR | 0.81% |
| 2022 | 847.09 Million INR | 4.06% |
| 2021 | 814.03 Million INR | 16.91% |
| 2020 | 696.29 Million INR | 43.34% |
| 2019 | 485.74 Million INR | 24.55% |
| 2018 | 390 Million INR | 33.6% |
| 2017 | 291.91 Million INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q4 | 853.96 Million INR | 0.94% |
| 2023 FY | 853.96 Million INR | 0.81% |
| 2023 Q2 | 846.02 Million INR | -0.13% |
| 2022 Q4 | 847.09 Million INR | 1.22% |
| 2022 Q2 | 836.85 Million INR | 2.8% |
| 2022 FY | 847.09 Million INR | 4.06% |
| 2021 FY | 814.03 Million INR | 16.91% |
| 2021 Q2 | 751.86 Million INR | 7.98% |
| 2021 Q4 | 814.03 Million INR | 8.27% |
| 2020 Q2 | 540.5 Million INR | 11.27% |
| 2020 FY | 696.29 Million INR | 43.34% |
| 2020 Q4 | 696.29 Million INR | 28.82% |
| 2019 Q4 | 485.74 Million INR | 10.69% |
| 2019 FY | 485.74 Million INR | 24.55% |
| 2019 Q2 | 438.81 Million INR | 12.52% |
| 2018 FY | 390 Million INR | 33.6% |
| 2018 Q4 | 390 Million INR | 30.38% |
| 2018 Q2 | 299.13 Million INR | 2.47% |
| 2017 FY | 291.91 Million INR | 0.0% |
| 2017 Q4 | 291.91 Million INR | 58.5% |
| 2017 Q2 | 184.17 Million INR | 33.98% |
| 2016 Q4 | 137.45 Million INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.78 Billion INR | 52.175% |
| Biocon Limited | 560.7 Billion INR | 99.848% |
| Blue Jet Healthcare Limited | 10.58 Billion INR | 91.935% |
| Concord Biotech Limited | 17 Billion INR | 94.979% |
| Dishman Carbogen Amcis Limited | 95.81 Billion INR | 99.109% |
| FERMENTA BIOTECH LIMITED | 5.47 Billion INR | 84.412% |
| GENOMIC VALLEY BIOTECH LIMITED | 43.33 Million INR | -1870.537% |
| Lyka Labs Limited | 1.56 Billion INR | 45.512% |
| Panacea Biotec Limited | 12.4 Billion INR | 93.117% |
| SAMSRITA LABS LIMITED | 155.51 Million INR | -449.128% |
| Servoteach Industries Limited | 1591.00 INR | -53674695.726% |
| SMS Lifesciences India Limited | 3.9 Billion INR | 78.133% |
| Supriya Lifescience Limited | 9.21 Billion INR | 90.73% |
| Syngene International Limited | 61.51 Billion INR | 98.612% |
| TAKE Solutions Limited | 881.05 Million INR | 3.074% |
| Titan Biotech Limited | 1.56 Billion INR | 45.461% |
| Transgene Biotek Limited | 324.4 Million INR | -163.242% |